Six Questions For Merck's Stein On Beating The Competition And Staying Relevant in Diabetes
This article was originally published in Scrip
During the European Association for the Study of Diabetes meeting in Stockholm this week, the severity of the current disease crisis was impressed upon delegates at every turn. Few presentations failed to include dire warnings of the increasing diabetes epidemic, followed by reminders that over half of those diagnosed with the disease are inadequately treated on current therapies.
Register for our free email digests: